Seven Oaks Closes $259M IPO

Seven Oaks Acquisition said it consummated its IPO of 25.875 million units, including 3.375 units as a result of the underwriters’ full exercise of their over-allotment option.

The units were sold at $10 each, generating gross proceeds to the Company of $258.75 million.

Simultaneously with the closing of the IPO, the SPAC completed the private sale of warrants to Seven Oaks Sponsor at a price of $1 each, generating gross proceeds of about $5.59 million.

The SPAC is focused on the Environmental, Social and Governance (“ESG”) sectors. Read more.

Total
0
Shares
Related Posts
Read More

Lazard Healthcare I Withdraws $250M IPO

The SPAC in its S-1 filing from March 2021 noted plans to target the biotechnology, medical technology, life science tools and diagnostics, healthcare information technology and technology-enabled healthcare services subsectors.